BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22

• Longevity

  July 15, 2025
• HIV

  July 15, 2025
• 

  Obesity

  Hengrui’s Dual GLP-1/GIP Elicits 17.7% Weight Loss in Phase III

  The molecule, developed in collaboration with Massachusetts-based Kailera Therapeutics, is headed for a new drug application in China and global clinical trials.

  July 15, 2025

   · 

  2 min read

   · 

  Dan Samorodnitsky
• 

  Job Trends

  Bonus Episode: Q1 2025 Job Market Update

  In this bonus episode, BioSpace’s Vice President of Marketing ⁠Chantal Dresner⁠ and Careers Editor ⁠Angela Gabriel⁠ take a look at Q2 job market performance, layoffs and wider employment trends and policies impacting the biopharma workforce.

  July 15, 2025

   · 

  1 min read

   · 

  Angela Gabriel
• 

  Layoffs

  HHS Begins Formally Laying Off Employees

  Thousands of employees across HHS were terminated Monday evening after the U.S. Supreme Court ruled last week that the Trump administration could move forward with its sweeping reorganization of the agency.

  July 15, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Policy

  FDA Commissioner Marty Makary Proposes Lowering Industry User Fees

  According to Makary, reducing user fees—which make up just under half of the FDA’s budget—could make it easier for smaller companies, individual investors and academics to participate in the process.

  July 15, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Infectious disease

  Gilead, GSK/ViiV, Merck Present New HIV PrEP Frontiers at IAS25

  HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the heels of the landmark Yeztugo approval.

  July 15, 2025

   · 

  4 min read

   · 

  Tristan Manalac
• 

  Rare diseases

  Acadia Debuts New Team, Pipeline With ‘Biotech Powerhouse’ Ambitions

  More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia since last year—are managing two products on the market and a pipeline estimated to be worth an additional $12 billion in sales.

  July 15, 2025

   · 

  5 min read

   · 

  Heather McKenzie
• Press Releases

  Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity

  July 15, 2025

   · 

  3 min read
• Press Releases

  CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

  July 15, 2025

   · 

  3 min read